The FDA has published its evidence to the National Crime Agency’s Pay Review Body, calling for a pay rise for NCA staff and for a quicker pace of pay reform.
The FDA, which represents senior managers and leaders in the NCA, has also called on the Agency to reflect on the lessons learned about flexible working throughout the COVID-19 pandemic and how this can be reflected in the overall reward package, and to consider a means to compensate staff for excess hours worked.
FDA National Officer for the NCA, Wynne Parry said:
“The government has failed to justify the public sector pay pause in its evidence to the Pay Review Body. FDA members in the NCA have worked extraordinarily hard throughout the pandemic and deserve to be properly rewarded for those efforts.
“While we recognise the efforts made by the NCA on pay reform, too many staff are yet to see any tangible benefit and continue to see no real improvement on pay progression. We have therefore urged the Pay Review Body to recommend a consolidated salary increase for NCA staff, alongside genuine progress on pay reform and a fresh approach to flexible working.”
The FDA will be giving oral evidence to the Pay Review Body on Wednesday 5 May.
You can find the FDA’s full written evidence here.
This week, the FDA attended the 2026 TUC Congress in Brighton. FDA delegates spoke to and moved motions on a range of topics, including the review of the civil service, supporting effective management, accountability and safe contracting in the NHS, and the importance of an evidence-led approach to regulation.
Yesterday, FDA staff and reps attended the 2026 Fast Stream annual Base Camp, welcoming this year’s new joiners to the scheme and sharing the benefits of FDA membership with them.
The FDA’s National Officer for Northern Ireland Robert Murtagh has written to Speaker of the Assembly, Edwin Poots, asking him to remind MLAs that when officials appear before the Assembly, impartiality must not be brought into question.
